VVT Med Inc.
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for leg vein; VAR-01, a treatment kit for leg varicosities; VAR-02, a treatment kit for shallow varicosities; VAR-P " 06, a treatment kit for perforant veins failure; and Spider-01, a treatment kit for spider ve… Read more
VVT Med Inc. (VVTM) - Total Assets
Latest total assets as of September 2025: CA$1.93 Million CAD
Based on the latest financial reports, VVT Med Inc. (VVTM) holds total assets worth CA$1.93 Million CAD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
VVT Med Inc. - Total Assets Trend (2022–2024)
This chart illustrates how VVT Med Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
VVT Med Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
VVT Med Inc.'s total assets of CA$1.93 Million consist of 37.6% current assets and 62.4% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 10.6% |
| Accounts Receivable | CA$25.00K | 2.5% |
| Inventory | CA$219.00K | 22.2% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$0.00 | 0.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2022–2024)
This chart illustrates how VVT Med Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: VVT Med Inc.'s current assets represent 37.6% of total assets in 2024, a decrease from 41.0% in 2022.
- Cash Position: Cash and equivalents constituted 10.6% of total assets in 2024, down from 17.1% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is inventory at 22.2% of total assets.
VVT Med Inc. Competitors by Total Assets
Key competitors of VVT Med Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
VVT Med Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - VVT Med Inc. generates 0.50x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - VVT Med Inc. is currently not profitable relative to its asset base.
VVT Med Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.76 | 0.06 | 0.06 |
| Quick Ratio | 0.64 | 0.02 | 0.02 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-457.00K | CA$ -6.34 Million | CA$ -6.34 Million |
VVT Med Inc. - Advanced Valuation Insights
This section examines the relationship between VVT Med Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 8.98 |
| Asset Growth Rate (YoY) | 10.8% |
| Total Assets | CA$985.00K |
| Market Capitalization | $8.84 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values VVT Med Inc.'s assets at a significant premium ( 8.98x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: VVT Med Inc.'s assets grew by 10.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for VVT Med Inc. (2022–2024)
The table below shows the annual total assets of VVT Med Inc. from 2022 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CA$985.00K | +10.80% |
| 2023-12-31 | CA$889.00K | +0.45% |
| 2022-12-31 | CA$885.00K | -- |